BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 5, 2016
View Archived Issues
Researchers investigate Nampt inhibitors without CYP2C9 inhibitory effects
Read More
PTC Therapeutics presents antibacterial compounds
Read More
First-in-human phase I results for the tuberculosis vaccine MVA85A-IMX313
Read More
Shire discloses dopamine transporter inhibitors
Read More
Shanghai Institute of Organic Chemistry patents indoleamine dioxygenase inhibitors
Read More
Proximagen Group presents amine oxidase inhibitors
Read More
SIMM, Suzhou Vigonvita Life Sciences and Topharman Shanghai develop antiepileptic compounds
Read More
Novartis divulges c-Raf inhibitors
Read More
Janssen files application for ibrutinib in Japan
Read More
Gilead Sciences acquires Nimbus Therapeutics' ACC inhibitor program
Read More
Single-dose and preservative-free formulation of Makena launched in the U.S.
Read More
Topical formulation of pritelivir enters phase I clinical testing
Read More
Portola and Daiichi Sankyo to develop andexanet alfa with edoxaban in Japan
Read More
Second phase II study of NP-001 will enroll patients using biomarker for enriched selection
Read More
Boehringer Ingelheim and Kyoto University to investigate new drugs for sensorineural hearing loss
Read More
Nerviano Medical Sciences licenses drug-linker technology to Oxford Biotherapeutics
Read More
Intrexon creates joint venture to develop treatment for type 1 diabetes
Read More
Intec Pharma enrolls first patient in pivotal phase III Parkinson's trial
Read More
Multiple sclerosis vaccine well tolerated in phase II study
Read More
MJFF awards grant to VCU for Parkinson's disease drug trial
Read More
Portable electronic nose shows promise for cancer diagnosis
Read More
FDA approves Gilead's Descovy for the treatment of HIV
Read More
Silence Therapeutics presents data from Atu-027-I-02 clinical trial
Read More
JAK2 shows promise as a prognostic biomarker in NPC
Read More
Acucela and UoM announce agreement for the development of an optogenetic gene therapy
Read More